Cargando…
Digitalized Adaptation of Oncology Trials during and after COVID-19
Autores principales: | Li, Guanqiao, Yin, Chen, Zhou, Yangzhong, Wang, Tongyan, Chen, Jing, Liu, Yang, Chen, Ting, Wang, Haixue, Zhang, Linqi, Chen, Xiaoyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338008/ https://www.ncbi.nlm.nih.gov/pubmed/32634378 http://dx.doi.org/10.1016/j.ccell.2020.06.018 |
Ejemplares similares
-
Surging publications on the COVID-19 pandemic
por: Li, Guanqiao, et al.
Publicado: (2021) -
Serologic response and safety of COVID-19 vaccination in HSCT or CAR T-cell recipients: a systematic review and meta-analysis
por: Ge, Chenghao, et al.
Publicado: (2022) -
Core principles for infection prevention in hemodialysis centers during the COVID-19 pandemic
por: Chen, Gang, et al.
Publicado: (2020) -
Single-arm trials for domestic oncology drug approvals in China
por: Zhang, Hong, et al.
Publicado: (2023) -
Simultaneous development of zanubrutinib in the USA and China
por: Li, Guanqiao, et al.
Publicado: (2020)